Prestige Consumer Healthcare Inc. · NYSE:PBH
Prestige Consumer Healthcare — FY2025 Earnings Presentation
23 slides from Prestige Consumer Healthcare's earnings presentation, May 8, 2025
Slide 1: Full-Year Fiscal 2025 Results
Full-Year Fiscal 2025 Results May 8th, 2025
Slide 2: Safe Harbor Disclosure
Safe Harbor Disclosure This presentation contains certain “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements regarding the Company’s expected financial performance, including revenues, organic revenue growth, diluted EPS, and f
Slide 3: Agenda for Today's Discussion
Agenda for Today’s Discussion I. FY 25 and Performance Recap II. Drivers Positioning Portfolio for Growth III. Financial Overview IV.FY 26 Outlook FULL-YEAR FY 25 RESULTS 3
Slide 4: I. FY 25 and Performance Recap
I. FY 25 and Performance Recap FULL-YEAR FY 25 RESULTS
Slide 5: Record FY 25 Results Driven by Proven Business Strategy
Record FY 25 Results Driven by Proven Business Strategy ◼ Record revenue of $1.138 billion, up 1.1% versus prior year FY 25 Sales ◼ Outperformance highlighted by strong International segment growth and GI Highlights category strength ◼ Summer’s Eve experienced stable performance versus prior year ◼
Slide 6: II. Drivers Positioning Portfolio for Growth
II. Drivers Positioning Portfolio for Growth FULL-YEAR FY 25 RESULTS
Slide 7: Portfolio Diversity Enables Nimble Marketing Strategy
Portfolio Diversity Enables Nimble Marketing Strategy Agility in Action ... ... Supported by Brand-Building Playbook Engaging Campaigns Insight Driven Innovation ~11% & Content ~8% Impactful claims FY 25 Category Growth* Expanded consumer Limited FY 25 Clear Eyes marketing need states opportunities
Slide 8: Continue to Drive Strong E-Commerce Growth
Continue to Drive Strong E-Commerce Growth E-Commerce as a % of Net Sales* ~16% Engaging ~14% +4x ~11% Content Driving Traffic ~4% & Conversion FY 19 FY 21 FY 23 FY 25 Continued strong performance continued across E-Commerce business Continuing to Upgrade User Experience *MULO+ Retail sales data and
Slide 9: Wide-Ranging Innovation to Address Consumer Need States
Wide-Ranging Innovation to Address Consumer Need States Product Development Initiatives Extend Brand Through Better Consumer Experience or Claims Innovate Through Technology or Forms New Categories Pediatric Mental Oral Stool Expansion Nausea Alertness Softener FULL-YEAR FY 25 RESULTS 9
Slide 10: III. Financial Overview
III. Financial Overview FULL-YEAR FY 25 RESULTS
Slide 11: Record Fourth Quarter and FY Performance Highlights
Record Fourth Quarter and FY 25 Performance Highlights FY 25 FY 24 7.0% Revenue of $296.5 million, up 7.9% vs. prior $296.5 year on an organic basis(1) $277.0 15.5% Q4 $104.4 $90.4 28.7% $1.32 $1.02 (2) (2) Revenue Adjusted EBITDA Adjusted EPS Adjusted EBITDA(2) of $104.4 million compared to $90.4 m
Slide 12: Detailed Financial Results for FY 25
Detailed Financial Results for FY 25 3 Months Ended 12 Months Ended FY 25 Comments Q4 FY 25 Q4 FY 24 % Chg FY 25 FY 24 % Chg ◼ Revenue up 1.2% organically(1) versus prior Total Revenue $ 296.5 $ 277.0 7.0% $ 1,137.8 $ 1,125.4 1.1% year Gross Profit 170.0 151.8 12.0% 634.5 624.4 1.6% – International
Slide 13: Consistent, Strong Free Cash Flow Continued in FY 25
Consistent, Strong Free Cash Flow Continued in FY 25 Adj. FY Free Cash Flow(2) & Net Leverage(3) Capital Allocation Highlights Significant debt reduction to 2.4x Net Leverage(3) $254 $239 $243 $222 $213 $52 million in share repurchases 4.2x Building cash balance in advance of future 3.8x 3.3x inorga
Slide 14: Disciplined Capital Allocation Priorities Unchanged
Disciplined Capital Allocation Priorities Unchanged Organic Long-Term Algorithm… 1 Invest in Current Brands to Drive Organic Growth 2 Pursue M&A That is Attractive to Shareholders Ample Capacity to Pursue Brands & Portfolios of Scale Anticipate approximately $1 billion total Free Cash Flow(4) over t
Slide 15: IV. FY 26 Outlook
III. FY 26 Outlook FULL-YEAR FY 25 RESULTS
Slide 16: Well-Positioned Against Volatile FY 26 Backdrop
Well-Positioned Against Volatile FY 26 Backdrop Potential Macro Overhang PBH Considerations & Assumptions Portfolio widely distributed in needs-based product Tariff Volatility & Uncertainty categories Diverse and predominately domestic supplier base Associated Inflationary Impacts Working with trust
Slide 17: Initial FY 26 Outlook
Initial FY 26 Outlook ◼ Remain well-positioned in dynamic economic environment ◼ Continue to emphasize brand-building on a diverse, needs-based portfolio Top Line Trends ◼ Revenues of $1,140 to $1,155 million — Organic growth, excluded projected FX headwind, of approximately 1% to 2% ◼ Diluted EPS o
Slide 18: Q&A
Q&A Prestige Consumer HEALTHCARE
Slide 19: Appendix
Appendix (1) Organic Revenue is a Non-GAAP financial measure and is reconciled to the most closely related GAAP financial measure in the attached Reconciliation Schedules and / or our earnings release dated May 8, 2025 in the “About Non-GAAP Financial Measures” section. (2) Adjusted Net Income, Dilu
Slide 20: Reconciliation Schedules
Reconciliation Schedules Organic Revenue Change Three Months Ended March 31, Year Ended March 31, 2025 2024 2025 2024 (In Thousands) GAAP Total Revenues $ 296,518 $ 276,991 $ 1,137,762 $ 1,125,357 Revenue Change 7.0% 1.1% Adjustments: Impact of foreign currency exchange rates - (2,262) - (1,482) Tot
Slide 21: Reconciliation Schedules (Continued)
Reconciliation Schedules (Continued) Adjusted Net Income & Adjusted Diluted EPS Three Months Ended March 31, Year Ended March 31, 2025 2024 2025 2024 Net Adjusted Net Adjusted Net Adjusted Net Adjusted Income EPS Income EPS Income EPS Income EPS (In Thousands, except per share data) GAAP Net Income
Slide 22: Reconciliation Schedules (Continued)
Reconciliation Schedules (Continued) Adjusted Free Cash Flow Projected Free Cash Flow (In millions) Projected FY 26 GAAP Net Cash provided by operating activities $ 255 Additions to property and equipment for cash (10) Projected FY 26 Non-GAAP Free Cash Flow $ 245 FULL-YEAR FY 25 RESULTS 22
Slide 23: FY 26 Financial Outlook
FY 26 Financial Outlook Metric Guidance ◼ $1.140 to $1.155 billion Revenue ◼ Organic growth of 1% to 2% Gross Margin ◼ ~56.5% Marketing ◼ ~14% of net revenue General & Administrative ◼ ~9.7% of net revenue Interest Expense ◼ ~$39 million in interest expense Tax Rate ◼ ~24% effective tax rate EPS ◼ $
Prestige Consumer Healthcare — FY2025 Earnings Presentation on 6ix